HBK Investments’s Endocyte, Inc. Common Stock ECYT Stock Holding History

HBK Investments’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-37,500	Closed	-$666K	–	1528
2018 Q3	$666K	Buy	+37,500	New	+$644K	0.01%	847

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

HBK Investments's ECYT Position: Q4 2018 in Review

HBK Investments sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 37,500 shares — an estimated $666K sold.

HBK Investments first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $666K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

HBK Investments reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
HBK Investments sold 37,500 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $666K.
HBK Investments first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
HBK Investments's Endocyte, Inc. Common Stock position peaked at $666K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.